Allelica's polygenic risk score data published in Circulation

(Halsin Partners) Data published in Circulation showed that Allelica's proprietary polygenic risk score analysis combined with LDL level helps determine those people at most risk from heart attack, including those potentially in need of treatment with statins or PCSK9 inhibitors.